Post

New research · Ophthalmology
Clinical ophthalmology (Auckland, N.Z.) · 2d
Cohort studyClinical ophthalmology (Auckland, N.Z.) · 2026

Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology.

Elif Demircan, David Rabinovitch, Iqbal Ike K Ahmed, Devesh K Varma
Read paper
OphthalmologyCohort study

Most patients were satisfied with vision after this extended-depth-of-focus lens implant.

Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology.

Elif Demircan … Devesh K Varma
Clinical ophthalmology (Auckland, N.Z.) · 2026
Purpose

To evaluate visual and patient-reported outcomes after bilateral implantation of a non-diffractive extended depth of focus (EDOF) IOL (AcrySof IQ Vivity, Alcon) in patients with early macular pathology.

Methods

Single-site, prospective, non-comparative pilot cohort study.

n = 40 eyes
Results
90%
9 in 10 said they were happy with how they saw after surgery
n = 40 eyes
More results

At 3 months, median (IQR) monocular corrected distance visual acuity, distance-corrected intermediate visual acuity, and distance-corrected near visual acuity were 0.00 (0.00-0.10), 0.18 (0.08-0.28), and 0.40 (0.30-0.50) logMAR, respectively.

More results

Binocular corrected distance visual acuity, distance-corrected intermediate visual acuity, and distance-corrected near visual acuity were 0.00 (0.00-0.00), 0.13 (0.08-0.18), and 0.35 (0.22-0.40).

Binocular UDVA, UIVA, and UNVA were 0.00 (0.00-0.00), 0.08 (-0.01-0.11), and 0.30 (0.20-0.33) logMAR, respectively.

“
Conclusion · 1 of 2

In patients with early macular pathology, bilateral implantation of a non-diffractive EDOF IOL demonstrated promising distance and intermediate vision, favorable near visual outcomes, and high patient satisfaction with minimal visual disturbances.

Conclusion · 2 of 2

Larger, prospective, comparative studies are warranted to define candidacy for patients with macular pathology.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment